These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33435656)

  • 1. [A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].
    Owa S; Sasaki T; Ishihara M; Watanabe S; Kato M; Sugino Y; Kato M; Masui S; Nishikawa K; Yoshio Y; Kanda H; Sugimura Y; Inoue T
    Hinyokika Kiyo; 2020 Dec; 66(12):449-452. PubMed ID: 33435656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modified BEP regimen leads to abatement of choriocarcinoma syndrome in a patient with extra gonadal germ cell tumor : a case report].
    Oshima J; Uemura M; Kato T; Nagahara A; Kiuchi H; Tsujimura A; Nonomura N
    Hinyokika Kiyo; 2014 Apr; 60(4):183-7. PubMed ID: 24882231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
    Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
    Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
    Tobiume M; Aoki S; Nishikawa G; Muramatsu H; Ono K; Morinaga S; Hara K; Ando N; Ono K; Nishibata C; Hidano A; Nakagawa M; Takahashi I; Matsubara K; Yamada Y
    J Med Case Rep; 2021 Feb; 15(1):59. PubMed ID: 33541424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Metachronous Testicular Tumor Developing Twenty Years after Treatment of Retroperitoneal Extragonadal Germ Cell Tumor].
    Tobiume M; Yamada Y; Aoki S; Hara K; Muramatsu H; Nishikawa G; Ono K; Takayanagi Y; Nakamura K
    Hinyokika Kiyo; 2020 Jun; 66(6):171-176. PubMed ID: 32605355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
    Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
    J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
    Yamashita T; Morozumi M; Takagi D; Yoshinaga A; Ishii N; Matsuda T; Terao T; Yamada T
    Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):565-9. PubMed ID: 20387517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
    Koterazawa S; Masui K; Hama Y; Takahashi Y; Sawada A; Akamatsu S; Kobayashi T
    Hinyokika Kiyo; 2022 Jun; 68(6):201-205. PubMed ID: 35850510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.
    Kimakura M; Abe T; Nagahara A; Fujita K; Kiuchi H; Uemura M; Nonomura N
    Anticancer Drugs; 2016 Apr; 27(4):364-8. PubMed ID: 26736135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
    Azrif M; Leong YK; Aslan NM; Fong KV; Ismail F
    Asian Pac J Cancer Prev; 2012; 13(6):2467-71. PubMed ID: 22938405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe Acute Myocardial Infarction during Induction Chemotherapy for Retroperitoneal Germ Cell Tumor : A Case Report].
    Sakka S; Kawai K; Tsujimoto I; Kurobe M; Ichioka D; Kantori S; Kojima T; Suetomi T; Jouraku A; Miyazaki J; Hoshi T; Nishiyama H
    Hinyokika Kiyo; 2016 Sep; 62(9):483-487. PubMed ID: 27760974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two Cases of Germ Cell Tumors with Hyperthyroidism Due to High Serum hCGLevels].
    Chihara I; Nitta S; Kimura T; Kandori S; Kawahara T; Waku N; Kojima T; Joraku A; Miyazaki J; Iwasaki H; Suzuki H; Kawai K; Nishiyama H
    Hinyokika Kiyo; 2016 Sep; 62(9):489-493. PubMed ID: 27760975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.